Development of bulk drug, medical device parks to help reduce India's import dependency: Gowda

25 Jun 2020 Evaluate

Union Minister of Chemicals and Fertilisers D V Sadananda Gowda has said that the development of bulk drug and medical device parks will not only reduce India's dependency on imports but will also be helpful in making it a major player in global pharma export. He said modalities of selection of locality of parks as well as of the beneficiaries under the production linked incentive (PLI) scheme should be based on some well-defined objective criteria to ensure orderly development of the parks.

The Minister noted that these schemes will increase competitiveness of domestic production of bulk drugs and medical devices due to benefits available in clusters in the form of state of art common infrastructure and logistics facilities. Stating that these schemes are the need of the hour, he said that it is necessary that medicines are produced in the country at cheaper rates in line with the government’s vision of making affordable medicines available to every citizen.

Meanwhile, the Union Cabinet had approved schemes for supporting development of three bulk drug parks and four medical device parks on March 21, 2020 in order to reduce dependency on imports for critical healthcare needs and boost local manufacturing and employment. 

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×